Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06222957 | The Effects of HER2 Receptor Signaling on Human Brown Fat Activity(HEAT) | recruiting | — | 30 | Rigshospitalet, DenmarkOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT06252662 | Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies | recruiting | Phase 4 | 200 | United States Naval Medical Center, PortsmouthFED | 1 | Nov 19, 2024 |
| clinicaltrials |
| NCT06452706 | The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer | recruiting | Phase 2 | 42 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 19, 2024 | clinicaltrials |
| NCT05933876 | The Impact of Radiotherapy on Oligometastatic Cancer | recruiting | — | 2,000 | Institut Investigacio Sanitaria Pere VirgiliOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT04787042 | Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 | recruiting | Phase 1 / Phase 2 | 316 | Simcha IL-18, Inc.INDUSTRY | 1 | Nov 15, 2024 | clinicaltrials |
| NCT06690645 | The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer | recruiting | — | 840 | Shengjing HospitalOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT06532812 | TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer(BAH249) | recruiting | Phase 1 / Phase 2 | 85 | Essen BiotechOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06677944 | Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer | recruiting | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT05063136 | Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer | recruiting | Phase 3 | 1,979 | Henan Cancer HospitalOTHER_GOV | 1 | Nov 4, 2024 | clinicaltrials |
| NCT05911958 | A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer | recruiting | Phase 2 | 66 | Henan Cancer HospitalOTHER_GOV | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06533384 | PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC | recruiting | Phase 3 | 310 | Guangdong Provincial People's HospitalOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06672497 | Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients | recruiting | — | 30 | University of South CarolinaOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06387901 | Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.(PABTOX) | recruiting | — | 40 | Universitair Ziekenhuis BrusselOTHER | 1 | Nov 1, 2024 | clinicaltrials |
| NCT05403554 | A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers | recruiting | Phase 1 | 70 | Light Chain Bioscience - Novimmune SAINDUSTRY | 2 | Oct 29, 2024 | clinicaltrials |
| NCT06166953 | The Effect of Digital Technology-Supported Education on Patients Undergoing Breast Reconstruction After Mastectomy: A Randomized Controlled Study | recruiting | N/A | 38 | Baskent UniversityOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT06660628 | Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer(DLLEB) | recruiting | N/A | 348 | Peking Union Medical College HospitalOTHER | 1 | Oct 28, 2024 | clinicaltrials |
| NCT06656624 | Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel) | recruiting | Phase 2 | 190 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT04289935 | Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer(VISION I) | recruiting | N/A | 420 | Klinik Hirslanden, ZurichOTHER | 4 | Oct 23, 2024 | clinicaltrials |
| NCT06415032 | Quilting Sutures After Mastectomy(BE-Quilt) | recruiting | N/A | 296 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT06643767 | Evaluation of the Bexa Breast Examination(BBE) | recruiting | N/A | 500 | Sure, Inc.INDUSTRY | 1 | Oct 18, 2024 | clinicaltrials |
| NCT06648148 | Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer | recruiting | — | 200 | Institute of Oncology LjubljanaOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT06649565 | Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy | recruiting | — | 300 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT06274892 | Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process(PROMOTE) | recruiting | N/A | 124 | University Health Network, TorontoOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT06639178 | Effectiveness of an N-acetylcysteine and Urea-based Cream in Prevention of Capecitabine-induced HAND-foot Syndrome in Breast Cancer Patients(HAND-TO-HAND) | recruiting | N/A | 25 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT04049214 | Perioperative Mindfulness Proposal | recruiting | N/A | 24 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05935150 | Omission of SLNB in CN0 Early Breast Cancer | recruiting | N/A | 311 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06641544 | The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer(IFANS) | recruiting | Phase 4 | 200 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06642948 | AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial(AiRE-MS) | recruiting | N/A | 80 | Fudan UniversityOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06632886 | AI-Assisted Non-Contrast CT for Multi-Cancer Screening | recruiting | N/A | 1,000,000 | Guo ShiWeiOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT06633601 | MRI-Guided Ultrasound Stimulated Microbubbles Radiation Treatment for Patients with Chest-Wall and Locally Advanced Breast Cancer | recruiting | Phase 1 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT05594095 | SNF Platform Study of HR+/ HER2-advanced Breast Cancer | recruiting | Phase 2 | 620 | Fudan UniversityOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT05878964 | Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.(SkinHealth) | recruiting | — | 420 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT06624917 | Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery Protocol(BuGs) | recruiting | N/A | 110 | University of Rome Tor VergataOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT06622954 | Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients(PROTECT-COR) | recruiting | N/A | 32 | Erasmus Medical CenterOTHER | 1 | Oct 2, 2024 | clinicaltrials |
| NCT05241405 | Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer(QISEIN) | recruiting | N/A | 354 | Centre Francois BaclesseOTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT04258280 | Improving Genetic Counseling for BRCA+ Mothers(PCS IV) | recruiting | N/A | 200 | Georgetown UniversityOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06185972 | Novel Magnetic Resonance Imaging-Guided Ultrasound-Stimulated Microbubble Radiation Treatment for Patients With Chest-Wall and Breast Cancer | recruiting | Phase 2 | 200 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06299202 | Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy(CERePred) | recruiting | N/A | 100 | Hospices Civils de LyonOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06615466 | Super-Hypofractionated Partial Breast Irradiation | recruiting | N/A | 50 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Sep 26, 2024 | clinicaltrials |
| NCT04344496 | East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction | recruiting | — | 2,000 | National Taiwan University HospitalOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT04547907 | A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer | recruiting | Phase 3 | 688 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 20, 2024 | clinicaltrials |
| NCT06489158 | Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade | recruiting | — | 168 | Peking Union Medical College HospitalOTHER | 1 | Sep 20, 2024 | clinicaltrials |
| NCT06605521 | To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients | recruiting | — | 300 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 20, 2024 | clinicaltrials |
| NCT05019690 | Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer | recruiting | Phase 1 / Phase 2 | 29 | Fujian Cancer HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05772390 | Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation(PBReI) | recruiting | Phase 2 | 68 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05841186 | Correlation of Timing of Pegfilgrastim Administration and PIBP. | recruiting | N/A | 156 | Guangdong Provincial People's HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06272799 | Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.(ATD) | recruiting | — | 160 | Regina Elena Cancer InstituteOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06342037 | NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial(TONIC-3) | recruiting | Phase 2 | 60 | The Netherlands Cancer InstituteOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06378944 | Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer(INSEAN) | recruiting | — | 15,000 | Omphis FoundationOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06559696 | Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy | recruiting | Phase 3 | 722 | Fujian Medical University Union HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Nov 19, 2024source: clinicaltrials